了解癌症对托皮索马酶活性药物的防御:综合性审查
Nilesh Kumar Sharma1, Anjali Bahot1, Gopinath Sekar1
1Cancer and Translational Research Centre Dr. D.Y. Patil Biotechnology & Bioinformatics Institute, Dr. D.Y. Patil Vidyapeeth, Pune 411033, Maharashtra, India.
Cancers
|February 24, 2024
概括
癌症耐药性是由瘤复杂性驱动的,阻碍了诸如拓酶活性药物之类的治疗方法. 了解抵抗机制和探索药物组合可以改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗癌药物耐药性是一个主要的挑战,其特点是遗传异质性和细胞复杂性.
- 机制包括氧化应激,免疫逃避,代谢重编程,ABC转运体过度表达和癌症干细胞特性.
- 拓糖酶活性药物 (例如,多克索鲁比辛,托波特坎) 是必不可少的,但经常面临抗药性,导致治疗失败.
研究的目的:
- 综合审查复杂的分子和细胞机制的耐药性,以拓酶活性药物.
- 探索潜在的组合策略,包括拓酶活性药物和耐药途径抑制剂.
主要方法:
- 文献综述和综合有关癌症药物耐药机制的当前研究.
- 对细胞内和细胞外抗药路径的分析.
- 对组合治疗方法的评估.
主要成果:
- 详细阐明了对拓酶活性剂的多种耐药性机制.
- 确定有助于抗药性的主要途径.
- 讨论组合疗法的协同作用潜力.
结论:
- 更深入地了解抵抗机制对于克服治疗局限性至关重要.
- 组合策略有望提高拓酶活性药物的疗效.
- 跨学科的方法对于开发有效的,超越耐药性的癌症治疗方法至关重要.
更多相关视频
10:13Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
2.6K
10:12Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
2.8K
相关概念视频
DNA Topoisomerases
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
